Nova Mentis Life Science Overview
Get informed when a big investor buys or sells
+ Follow-1.96
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, NOVA.CN shows a P/E ratio of -1.96. That is below the Healthcare sector average of 22.57. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 22.57. Nova Mentis Life Science is at -1.96, which is lower that average. That is roughly 108.7% below the sector mean. Use the comparison chart on this page to see how NOVA.CN stacks up against individual peers as well.
Investors watch NOVA.CN's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Nova Mentis Life Science's latest reading is -1.96. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Nova Mentis Life Science's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -1.96) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 22.57, while NOVA.CN is at -1.96. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
